Bicyclol sustained-release tablets(Guangshengyu Pharma)

双环醇缓释片（广升誉制药）

Report date: 2025/04/17 10:17:51

Base Information

Drug NameBicyclol sustained-release tablets(Guangshengyu Pharma)
Drug Alias Name双环醇缓释片（2.2类改良型）
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein kinase C inhibitors
TargetsProtein kinase C
Therapy Area/IndicationsHepatitis, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesHainan Guangshengyu Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesHainan Guangshengyu Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A